People at 'intermediate risk' of heart disease with elevated hsCRP benefit from statin therapy
Wednesday, August 25, 2010 - 06:28
in Health & Medicine
Women and men with a 10-year cardiovascular disease risk of 5 percent or more and normal cholesterol levels but high levels of hsCRP, a protein associated with inflammation, could reduce their risk substantially with statin therapy, according to new research...